Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC)

By Monnet I.   Brienza S.   Hugret F.   Voisin S.   Gastiaburu J.   Saltiel J.C.   Soulie P.   Armand J.P.   Cvitkovic E.   de Cremoux H.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1124-1127

Elsevier

Access to resources Recommend Favorite

A Phase I/II Study of Dose-Intense Paclitaxel with Cisplatin and Cyclophosphamide as Initial Therapy of Poor-Prognosis Advanced-Stage Epithelial Ovarian Cancer

By Kohn E.C.   Sarosy G.A.   Davis P.   Christian M.   Link C.E.   Ognibene F.P.   Sindelar W.F.   Jacob J.   Steinberg S.M.   Premkumar A.   Reed E.  

Gynecologic Oncology, Vol. 62, Iss. 2, 1996-08 ,pp. : 181-191

Academic Press

Access to resources Recommend Favorite

Poor Prognosis of Advanced Gastric Cancer with Metastatic Suprapancreatic Lymph Nodes

By Kusano Toru   Shiraishi Norio   Shiroshita Hidefumi   Etoh Tsuyoshi   Inomata Masafumi   Kitano Seigo  

Annals of Surgical Oncology, Vol. 20, Iss. 7, 2013-07 ,pp. : 2290-2295

Springer Publishing Company

Access to resources Recommend Favorite

Increased urothelial cancer associated 1 is associated with tumor proliferation and metastasis and predicts poor prognosis in colorectal cancer

By                      

International Journal of Oncology, Vol. 47, Iss. 4, 2015-01 ,pp. : 1329-1338

Spandidos Publications

Access to resources Recommend Favorite

Bolus Mitomycin C and 5-FU with Sequential Radiation for Poor-Prognosis Locally Advanced Cervical Cancer

By denehy T.R.   Eastman R.   SanFilippo L.   Gregori C.A.   Breen J.L.  

Gynecologic Oncology, Vol. 60, Iss. 1, 1996-01 ,pp. : 64-71

Academic Press

Access to resources Recommend Favorite